From hospital haematology to leading early stage clinical trials, Margaret Irwin has built a career defined by curiosity, perseverance, and innovation. In this interview, she reflects on the unexpected journey that brought her into clinical research, the ... See more
Fujifilm Biotechnologies unveils ShunzymeX purification technology for biologics
FUJIFILM Biotechnologies has unveiled ShunzymeX, a purification technology designed to simplify downstream processing for complex biologics.
The contract development and manu... See more
Hemab Therapeutics wins FDA breakthrough therapy status for sutacimig in Glanzmann thrombasthenia
The FDA has granted breakthrough therapy designation to Hemab Therapeutics’ sutacimig to prevent bleeding in people with the rare disorder Glanzmann thrombas... See more
Outpost Bio raises $3.5M pre-seed to build AI models of human microbiology
Outpost Bio has raised $3.5m in a pre-seed round to develop computational models of human microbiology, aiming to help pharma and consumer health companies better predict how micro... See more
Insilico nominates pan-KRAS candidate ISM6166 after tumour regression in preclinical studies
Insilico Medicine has nominated ISM6166 as a preclinical candidate, positioning the oral pan-KRAS inhibitor to target a broad range of solid tumours historically ... See more
